未登录

E

Ellen J. Hess

Emory University

H指数:49

被引数:7,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Muscle ATP homeostasis and exercise: insights from ADSS1 myopathy

肌肉ATP稳态与运动：来自ADSS1肌病的见解

Molecular Genetics and Metabolism

IF3.5

2026-09-250

PRE

Changes in Purine Metabolism During Differentiation of Dopamine Neurons from Human Induced Pluripotent Stem Cells

人诱导多能干细胞分化为多巴胺能神经元期间嘌呤代谢的变化

Cellular and Molecular Neurobiology

IF4.8

2026-05-190

OAAI

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line

利用基因编辑诱导多能干细胞模拟罕见遗传病：起始细胞系的重要性

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2025-12-010

PRE

Modeling rare genetic disease with patient-derived induced pluripotent stem cells: reassessment of the minimum numbers of lines needed

利用患者来源的诱导多能干细胞模拟罕见遗传病：所需最少细胞系的重新评估

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2025-08-012

PRE

Striatal cell-type–specific molecular signatures reveal potential therapeutic targets in a model of dystonia

纹状体细胞类型特异性分子特征揭示了一个肌张力障碍模型中的潜在治疗靶点

Neurobiology of Disease

IF5.6

2025-05-280

OA

Report Spiny projection neurons exhibit transcriptional signatures within subregions of the dorsal striatum

IF6.9

2023-11-013

OAAI

Development of Novel M4 Muscarinic Acetylcholine Receptor Antagonists for the Treatment of Movement Disorders

IF4.2

2022-05-130

PRE

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

NEUROBIOLOGY OF DISEASE

IF5.6

2022-05-0126

OAAI

Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders

MOLECULAR GENETICS AND METABOLISM

IF3.5

2021-08-018

OAAI

Synaptic effects of ethanol on striatal circuitry: therapeutic implications for dystonia

IF4.2

2021-07-164

OAAI

Cell-intrinsic effects of TorsinA(δE) disrupt dopamine release in a mouse model of TOR1A dystonia

NEUROBIOLOGY OF DISEASE

IF5.6

2021-07-0110

OAAI

Induced pluripotent stem cells from subjects with Lesch-Nyhan disease

SCIENTIFIC REPORTS

IF3.9

2021-04-1911

OAAI

The neurobiological basis for novel experimental therapeutics in dystonia

NEUROBIOLOGY OF DISEASE

IF5.6

2019-10-0123

OAAI

Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia

NEUROBIOLOGY OF DISEASE

IF5.6

2019-05-0129

OAAI

Striatal Cholinergic Interneurons in a Knock-in Mouse Model of L-DOPA-Responsive Dystonia

FRONTIERS IN SYSTEMS NEUROSCIENCE

IF3.5

2018-06-2713

OAAI

Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2018-04-0118

OAAI

Evolving concepts in the pathogenesis of dystonia

PARKINSONISM & RELATED DISORDERS

IF3.4

2018-01-0135

OAAI

Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels

PSYCHOPHARMACOLOGY

IF3.3

2017-10-3014

OAAI

Parkinsonism Without Dopamine Neuron Degeneration in Aged L-Dopa-Responsive Dystonia Knockin Mice

MOVEMENT DISORDERS

IF7.6

2017-09-2610

OAAI

A new knock-in mouse model of L-DOPA-responsive dystonia

IF11.7

2015-07-2747

OAAI